Compare KGS & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KGS | INDV |
|---|---|---|
| Founded | 2011 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 4.1B |
| IPO Year | 2023 | N/A |
| Metric | KGS | INDV |
|---|---|---|
| Price | $49.95 | $34.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $43.50 | $35.75 |
| AVG Volume (30 Days) | 1.4M | ★ 1.7M |
| Earning Date | 02-25-2026 | 02-19-2026 |
| Dividend Yield | ★ 4.14% | N/A |
| EPS Growth | ★ 224.29 | N/A |
| EPS | 0.84 | ★ 0.98 |
| Revenue | ★ $1,284,748,000.00 | $1,180,000,000.00 |
| Revenue This Year | $13.95 | $2.27 |
| Revenue Next Year | $7.04 | N/A |
| P/E Ratio | $56.17 | ★ $33.60 |
| Revenue Growth | ★ 19.43 | N/A |
| 52 Week Low | $29.25 | $7.62 |
| 52 Week High | $48.47 | $38.00 |
| Indicator | KGS | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 84.54 | 54.47 |
| Support Level | $41.02 | $33.49 |
| Resistance Level | $42.27 | $35.59 |
| Average True Range (ATR) | 1.40 | 1.16 |
| MACD | 0.79 | 0.10 |
| Stochastic Oscillator | 95.31 | 78.52 |
Kodiak Gas Services Inc is an operator of contract compression infrastructure in the United States. It manages business through two operating segments namely Contract Services and Other Services. Contract Services consists of operating Company-owned and customer-owned compression, and gas treating and cooling infrastructure, pursuant to fixed-revenue contracts to enable the production and gathering of natural gas and oil. Other Services consist of a full range of contract services to support the ancillary needs of customers, including station construction, maintenance and overhaul, freight and crane charges, and other time and material-based offerings.
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.